Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

This study has been completed.
Sponsor:
Collaborators:
Dutch Cancer Society
Novartis
Information provided by (Responsible Party):
Hans J. van der Vliet, MD, PhD, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01462214
First received: October 10, 2011
Last updated: May 9, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2017
  Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):